Medical News

RSS

Text messaging technology has important implications for public health initiatives, finds study

A recent study conducted by the Center for Connected Health, a division of Partners HealthCare, found that text messaging is an innovative, low-cost and effective way to improve the daily use of sunscreen, and this technology may have important implications for larger-scale public health initiatives.

4 Dec 2009

Breastfeeding a child may lower a woman's risk of developing Metabolic Syndrome

Breastfeeding a child may lower a woman's risk of developing Metabolic Syndrome, a condition linked to heart disease and diabetes in women, according to a Kaiser Permanente study that was published today online ahead of print and will appear in the February issue of Diabetes, a journal of the American Diabetes Association.

4 Dec 2009

BioMed Realty Trust receives additional space at Landmark under new lease agreement

BioMed Realty Trust, Inc. announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) for approximately 131,000 square feet of additional, newly-constructed laboratory and office space at The Landmark at Eastview campus in Tarrytown, New York.

4 Dec 2009

RemedyMD launches first nationwide Pediatric Diabetes Registry

RemedyMD (www.RemedyMD.com), the leading provider of Disease Registry software, today announced the first nationwide Pediatric Diabetes Registry. The new registry was developed to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.

4 Dec 2009

Researchers discover new strategy against invasive parasite

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a possible strategy against an invasive parasite that infects more than a quarter of the world's population, including 50 million Americans.

4 Dec 2009

Alkermes licenses Medifusion technology to develop TNF receptor-Fc fusion protein

Alkermes, Inc. and Acceleron Pharma, Inc. today announced that Alkermes has licensed a proprietary long-acting Fc fusion technology platform, called the Medifusion™ technology, which is designed to extend the circulating half-life of proteins and peptides.

4 Dec 2009

U.N.-backed report features recommendations to scale up fight against HIV/AIDS in Pacific

A report released Wednesday by the Commission on AIDS in the Pacific region outlines the challenges of preventing the spread of HIV in "22 geographically and culturally diverse countries" of the Pacific and recommends efforts to scale up the region's fight against HIV/AIDS, U.N. News Centre reports.

4 Dec 2009

WHO investigates Tamiflu resistance, updates antiviral recommendations for H1N1 patients with severely compromised immune systems

Following recent reports of clusters of Tamiflu resistance, the WHO on Wednesday recommended that patients with severely weakened immune systems who become infected with the H1N1 (swine flu) virus receive additional antiviral treatment as needed throughout the duration of their illness, Agence France-Presse reports. "

4 Dec 2009

Presbia's Flexivue lens obtains CE certification

Presbia, a leader in the development and marketing of a surgical solution for presbyopia, today announced its Flexivue™ micro-lens received CE certification for its products sold within the European Economic Area (EEA). Specifically, the CE mark certifies that Flexivue™ has met European Union consumer safety, health and environmental requirements.

4 Dec 2009

Update on European commercial launch of MuGard for oral mucositis provided

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy.

4 Dec 2009

NeoPharm and Diosynth settle dispute resolution

NeoPharm, Inc. (Other OTC: NEOL.PK), announced today that it has reached a settlement agreement with Diosynth, RTP (“Diosynth”). As previously noted, NeoPharm reported that it had entered into various contractual arrangements with Diosynth to secure access to manufacturing capacity for the potential manufacture and regulatory advancement of Cintredekin Besudotox through early 2008.

4 Dec 2009

PlusNews examines push to evaluate HIV prevention strategies

PlusNews examines the growing need to test how well HIV prevention strategies work - a topic addressed Monday at a Social Aspects of HIV/AIDS Research Alliance (SAHARA) conference in Johannesburg, South Africa.

4 Dec 2009

Geisinger Medical Center opens new ‘Vestibular and Balance Center’

Geisinger Medical Center recently opened a new Otolaryngology Head and Neck Surgery - Vestibular and Balance Center to help patients who are affected by vertigo, dizziness or balance problems.

4 Dec 2009

Opinions: Media coverage of HIV/AIDS; WTO and global health; G8, HIV/AIDS; stopping syringe reuse

In a New Republic/NPR opinion piece, Harold Pollack, an associate professor at the University of Chicago School of Social Service Administration, looks at the media's coverage of World AIDS Day. "Almost six thousand people died of AIDS [Tuesday]. ... That it happened to be World AIDS Day was almost incidental. AIDS was certainly incidental to much of the mainstream media.

4 Dec 2009

Combination of green tea and DAPH-12 chemicals may help prevent brain disorders

Scientists at Boston Biomedical Research Institute (BBRI) and the University of Pennsylvania have found that combining two chemicals, one of which is the green tea component EGCG, can prevent and destroy a variety of protein structures known as amyloids. Amyloids are the primary culprits in fatal brain disorders such as Alzheimer's, Huntington's, and Parkinson's diseases.

4 Dec 2009

New biochemical probe may help in identifying toxic proteins associated with Alzheimer's disease

Alzheimer's disease (AD) is one of the most heartbreaking diagnoses a person can receive. This irreversible, progressive brain disease slowly destroys memory and thinking skills and eventually even the ability to carry out the simplest tasks

4 Dec 2009

Option Six acquired by GP Strategies

GP Strategies Corporation, announced that its principal operating subsidiary, global performance improvement solutions provider General Physics Corporation, has acquired Option Six, Inc., a provider of custom courseware development with expertise in the software and pharmaceutical industries.

4 Dec 2009

Discovery of antibiotic molecule may lead to the development of potent antibacterial drugs

An antibiotic that binds to a well-established target in a novel and unexpected way could be the inspiration for designing new, more potent antibacterial drugs.

4 Dec 2009

Geisinger Health System and Philips VISICU team up to launch eICU Program

Geisinger Health System recently signed an agreement with Philips VISICU, to launch an eICU Program® that will enhance physicians' ability to care for Geisinger's sickest patients.

4 Dec 2009

General Mills' new website provides information on gluten-free products

General Mills has created liveglutenfreely.com to provide consumers with information on gluten-free products and gluten-free recipes. The site lists General Mills products labeled gluten-free and features kitchen-tested recipes for preparing an array of gluten-free foods.

4 Dec 2009

Medical News

Text messaging technology has important implications for public health initiatives, finds study

Breastfeeding a child may lower a woman's risk of developing Metabolic Syndrome

BioMed Realty Trust receives additional space at Landmark under new lease agreement

RemedyMD launches first nationwide Pediatric Diabetes Registry

Researchers discover new strategy against invasive parasite

Alkermes licenses Medifusion technology to develop TNF receptor-Fc fusion protein

U.N.-backed report features recommendations to scale up fight against HIV/AIDS in Pacific

WHO investigates Tamiflu resistance, updates antiviral recommendations for H1N1 patients with severely compromised immune systems

Presbia's Flexivue lens obtains CE certification

Update on European commercial launch of MuGard for oral mucositis provided

NeoPharm and Diosynth settle dispute resolution

PlusNews examines push to evaluate HIV prevention strategies

Geisinger Medical Center opens new ‘Vestibular and Balance Center’

Opinions: Media coverage of HIV/AIDS; WTO and global health; G8, HIV/AIDS; stopping syringe reuse

Combination of green tea and DAPH-12 chemicals may help prevent brain disorders

New biochemical probe may help in identifying toxic proteins associated with Alzheimer's disease

Option Six acquired by GP Strategies

Discovery of antibiotic molecule may lead to the development of potent antibacterial drugs

Geisinger Health System and Philips VISICU team up to launch eICU Program

General Mills' new website provides information on gluten-free products

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News